LIDOCAINE HCI

N/A

Manufactured by Aurobindo Pharma Limited

47 FDA adverse event reports analyzed

Last updated: 2026-04-15

About LIDOCAINE HCI

LIDOCAINE HCI is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Aurobindo Pharma Limited. The most commonly reported adverse reactions for LIDOCAINE HCI include ABDOMINAL DISTENSION, ASTHENIA, DIARRHOEA, FATIGUE, NAUSEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for LIDOCAINE HCI.

Top Adverse Reactions

ABDOMINAL DISTENSION2 reports
ASTHENIA2 reports
DIARRHOEA2 reports
FATIGUE2 reports
NAUSEA2 reports
ABDOMINAL PAIN1 reports
ACNE1 reports
AGITATION1 reports
ALOPECIA1 reports
BLOOD GLUCOSE DECREASED1 reports
BLOOD POTASSIUM INCREASED1 reports
BRADYCARDIA1 reports
CLOSTRIDIUM DIFFICILE COLITIS1 reports
COLITIS ISCHAEMIC1 reports
COUGH1 reports
COVID 191 reports
DEATH1 reports
DIABETES MELLITUS1 reports
DIVERTICULITIS1 reports
DYSPNOEA1 reports
FLUSHING1 reports
HYPERTENSION1 reports
HYPOTENSION1 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES1 reports
MALAISE1 reports
MENTAL STATUS CHANGES1 reports
METASTASES TO LYMPH NODES1 reports
PARAESTHESIA1 reports
PARAPLEGIA1 reports
PLEURAL EFFUSION1 reports
PNEUMONIA1 reports
PRODUCT DISTRIBUTION ISSUE1 reports
PYREXIA1 reports
RENAL FAILURE CHRONIC1 reports
SEPSIS1 reports
SKIN FISSURES1 reports
TACHYCARDIA1 reports
THERAPY INTERRUPTED1 reports
URINARY RETENTION1 reports
VOMITING1 reports
WHITE BLOOD CELL COUNT INCREASED1 reports
WRONG DRUG ADMINISTERED1 reports

Report Outcomes

Out of 9 classified reports for LIDOCAINE HCI:

Serious 44.4%Non-Serious 55.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female6 (66.7%)
Male3 (33.3%)

Reports by Age

Age 582 reports
Age 211 reports
Age 491 reports
Age 541 reports
Age 561 reports
Age 721 reports
Age 741 reports
Age 751 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with LIDOCAINE HCI?

This profile reflects 47 FDA FAERS reports that mention LIDOCAINE HCI. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for LIDOCAINE HCI?

Frequently reported terms in FAERS include ABDOMINAL DISTENSION, ASTHENIA, DIARRHOEA, FATIGUE, NAUSEA, ABDOMINAL PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures LIDOCAINE HCI?

Labeling and FAERS entries often list Aurobindo Pharma Limited in connection with LIDOCAINE HCI. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.